SEARCH

SEARCH BY CITATION

References

  • 1
    Rönnblom A, Forsberg H, Danielsson Å. Gastrointestinal symptoms in myotonic dystrophy. Scand J Gastroenterol 1996; 31: 654 7.
  • 2
    Nowak TW, Anuras S, Brown BP. Small intestinal motility in myotonic dystrophy. Gastroenterology 1984; 86: 808 13.
  • 3
    Debas TH & Mulvihill SJ. Neuroendocrine design of the gut. Am J Surg 1991; 161: 243 9.
  • 4
    Ekblad E, Håkansson R, Sundler F. Microanatomy and chemical coding of peptides-containing neurons in the digestive tract. In: Daniel E, ed. Neuropeptides Function in Gastrointestinal Tract. Boca Raton: CRC Press, 1991; 131 80.
  • 5
    Harvey RF. Hormonal control of gastrointestinal motility. Am J Dig Dis 1975; 20: 523 39.
  • 6
    Sjölund K, Sandén G, Håkansson R, Sundler F. Endocrine Cells in Human Intestine. An immunocytochemical study. Gastroenterology 1983; 85: 1120 30.
  • 7
    El-Salhy M, Stenling R, Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol 1993; 28: 809 15.
  • 8
    Cetin Y. Chromogranin A immunoreactivity and Grimelius' argyrophilia. A correlative study in mammalian endocrine cells. Anat Embryol 1992; 185: 207 15.
  • 9
    Cetin Y, Muller-Koppel L, Aunis D, Bader MF, Grube D. Chromogranin A (Cg A) in the gastro-entero-pancreatic (GEP) endocrine system. II. Histochem 1989; 92: 265 75.
  • 10
    Bargsten G & Grube D. Serotonin storage in chromogranins: an experimental study in rat gastric endocrine cells. J Histochem Cytochem 1992; 40: 1147 55.
  • 11
    Hörsch D, Wiehe E, Müller S, Hancke E. Distribution and coexistence of chromogranin A-, serotonin- and pancreastatin-like immunoreactivity in endocrine-like cells of the human anal canal. Cell Tissue Res 1992; 268: 109 16.
  • 12
    El-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 1994; 35: 1413 8.
  • 13
    Pietroletti R, Bishop AE, Carlei F, Bonamico M, Lloyd RV, Wilson B et al Gut endocrine cell population in coeliac disease estimated by immunocytochemistry using a monoclonal antibody to chromogranin. Gut 1986; 27: 838 43.
  • 14
    Koch TR, Carney JA, Go VL. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 1987; 32: 369 76.
  • 15
    Sjölund K & Ekman R. Increased plasma levels of peptide YY in coeliac disease. Scand J Gastroenterol 1988; 23: 297 300.
  • 16
    Harper PS, Penny R, Foley JRTP, Mignon CJ, Blizzard RM. Gonadal function in males with myotonic dystrophy. J Clin Endocrinol Metab 1972; 35: 852 6.
  • 17
    Huff TA, Horton ES, Lebowitz HE. Abnormal insulin secretion in myotonic dystrophy. N Engl J Med 1967; 277: 837 41.
  • 18
    Mishra SK, Chetty S, Kataoka M. Abnormal insulin receptor binding in cultured monocytes in myotonic dystrophy. Biochem Med Metab Biol 1992; 47: 161 7.
  • 19
    Grice JE, Jackson RV, Hockings GI, Torpy DJ, Walters MM, Crosbie GV. Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophy. J Clin Endocrinol Metab 1995; 80: 179 84.